PExA

About PExA

PExA AB is a Swedish medical technology company that develops innovative solutions for analyzing and monitoring particles in exhaled air. The company's technology enables early diagnosis and better understanding of lung diseases by measuring microscopic particles from the lungs. PExA was founded in 2006 and is headquartered in Gothenburg.

Kategori

All

Hot Chair

Video interviews

Tomas Gustafsson, CEO at PExA AB

2024-07-08

Hot Chair - PExA

Tomas Gustafsson, CEO of PExA AB (publ), describes how PExA is developing innovative instruments for non-invasive sampling of small airways in the lungs, which opens up new opportunities for research and diagnostics.

The company sells and rents its instruments globally and is now conducting a 7.4 MSEK share issue to strengthen marketing and participate in international congresses. The PExA market includes both research instruments and future diagnostics, with the potential to revolutionize the detection and treatment of lung diseases.

Read more
Read more
Lungs

2024-04-11

Hot Chair - PExA

Tomas Gustafsson, CEO of PExA AB (publ), highlights the company's unique technology that is changing lung research.

With an innovative instrument that enables the collection of samples from the small airways of the lungs, Tomas demonstrates how PExA opens up new possibilities for early detection and treatment of lung diseases. The company's customer base encompasses the global research community and ranges from studies related to the work environment to research on lung cancer.

Read more
Read more
Picture of some participants at the Investment Meeting

2024-04-04

Impala Invest investor meeting in Gothenburg

On March 21, Impala Invest organized an investor meeting in Gothenburg where Diagonal Bio AB, Hoi Publishing AB, PExA AB and Carbiotix AB presented.

The engagement from investors was strong, resulting in relevant questions and fruitful discussions.

Read more
Video interviews

Select your language:

Engelsk flag
EN
Tysk flag
SE